2015

• 2015-21/ Identification of a cytotoxic molecule in heat-modified citrus pectin

Leclere L¹, Fransolet M², Cambier P³, El Bkassiny S⁴, Tikad A⁵, Dieu M⁶, Vincent SP⁷, Van Cutsem P⁸, Michiels C⁹

• 2015-20/ Unleashing Cancer Cells on Surfaces Exposing Motogenic IGDQ Peptides

Corvaglia V^1,2, Marega R¹, De Leo F¹, Michiels C³, Bonifazi D^1,2

• 2015-19/ Biotechnological promises of Fe-filled CNTs for cell shepherding and magnetic fluid hyperthermia applications

Pineux F¹, Marega R¹, Stopin A¹, La Torre A², Garcia Y³, Devlin E⁴, Michiels C⁵, Khlobystov AN², Bonifazi D⁶

• 2015-18/ Physicochemical and toxicological evaluation of silica nanoparticles suitable for food and consumer products collected by following the EC recommendation

Contado C¹, Mejia J², Lozano García O², Piret JP³, Dumortier E³, Toussaint O³, Lucas S²

• 2015-17/ Towards predicting the lung fibrogenic activity of MWCNT: Key role of endocytosis, kinase receptors and ERK 1/2 signaling

Vietti G¹, Ibouraadaten S¹, Palmai-Pallag M¹, Yakoub Y¹, Piret JP², Marbaix E³, Lison D¹, van den Brule S¹

• 2015-16/ Connecting Mitochondria, Metabolism, and Stem Cell Fate

Wanet A¹, Arnould T¹, Najimi M², Renard P¹.

• 2015-15/ M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide

Genin M¹, Clement F², Fattaccioli A³, Raes M⁴, Michiels C⁵

• 2015-14/ Mitochondria Retrograde Signaling and the UPRmt: Where Are We in Mammals?

Arnould T¹, Michel S^2,3, Renard P⁴

• 2015-13/ Quality control data of physiological and immunological biomarkersmeasured in serum and plasmaEugène

plasmaEugène Jansena,∗, Piet Beekhofa, Johannes Cremersa, Birgit Weinbergerb, Simone Fieglc,Olivier Toussaintd, Jürgen Bernharde, Efstathios Gonosf, Miriam Caprig,Claudio Franceschig, Ewa Sikorah, María Moreno-Villanuevai, Nicolle Breusingj,Tilman Grunek, Alexander Bürklel, Martijn E.T. Dolléa

• 2015-12/ Monte Carlo Calculation of Radioimmunotherapy with 90Y-, 177Lu-, 131I-, 124I-, and 188Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts

S. Lucas,1,2 O. Feron,3 B. Gallez,4 B. Masereel,2,5 C. Michiels,2,6 and T. Vander Borght2,7

• 2015-11/ Lipin-­1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment

Laura Brohée1, Stéphane Demine2, Jérome Willems1, Thierry Arnould2, Alain C. Colige1 and Christophe F. Deroanne1